{"url_path":"/sec/nord/10-k/2026/item-12","section_key":"item-12","section_title":"Item 12 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-07-14","source_url":"https://www.sec.gov/Archives/edgar/data/1011060/0001493152-26-033203-index.html","accession_number":"0001493152-26-033203","cik":"0001011060","ticker":"NORD","issuer_name":"Nordicus Partners Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1011060/0001493152-26-033203-index.html","primary_entity_key":"0001011060","primary_entity_name":"Nordicus Partners Corp"},"word_count":636,"has_tables":true,"body_markdown":"**Item\n12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters**\n\n** **\n\nThe\nfollowing table sets forth the beneficial ownership of shares of our common stock, as of June 18, 2026 of (i) each person known by us\nto beneficially own five percent (5%) or more of such shares; (ii) each of our directors and current executive officers named in the\nSummary Compensation Table; and (iii) our current executive officers and directors as a group. Except as otherwise indicated, all shares\nare beneficially owned, and the persons named as owners hold investment and voting power.\n\n \n\n24\n\n \n\n \n\nBeneficial\nownership has been determined in accordance with Rule 13d-3 under the Securities Exchange Act of 1934. Under this rule, certain shares\nmay be deemed to be beneficially owned by more than one person, if, for example, persons share the power to vote or the power to dispose\nof the shares. In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire shares, for\nexample, upon exercise of an option or warrant, within 60 days of June 18, 2026. In computing the percentage ownership of any person,\nthe amount of shares is deemed to include the amount of shares beneficially owned by such person, and only such person, by reason of\nsuch acquisition rights. As a result, the percentage of outstanding shares of any person as shown in the following table does not necessarily\nreflect the person’s actual voting power at any particular date.\n\n \n\nName and Address of Beneficial Owner \n\nAmount and\n\nNature of\n\nBeneficial\n\nOwnership\n  \nPercentage of\nClass (1) \n\nHenrik Rouf (CEO)\n280 S. Beverly Dr., Suite 505\nBeverly Hills, CA 90212\nUSA \n 265,973(2) \n 1.4%\n\n  \n    \n   \n\nBennett Yankowitz (CFO & Director)\n280 S. Beverly Dr., Suite 505\nBeverly Hills, CA 90212\nUSA \n 150,000(3) \n 0.8%\n\n  \n    \n   \n\nHenrik Keller (Former Director)\nBernstoffslund Alle 59\n2920 Charlottenlund\nDenmark \n 25,000 \n 0.1%\n\n  \n    \n   \n\nPeter Severin (Director/Chairman)\nBlaamunkevangen 1\n3120 Dronningmoelle\nDenmark \n 50,000  \n 0.3%\n\n  \n    \n   \n\nAndrew J. Ritter (Director)\n11811 San Vicente Blvd.\nLos Angeles, CA 90049\nUSA \n 50,000  \n 0.3%\n\n  \n    \n   \n\nKim T. Mucke (Director)\nOesterbrogade 110, 3_\n2100 Copenhagen Oe\nDenmark \n 97,399(4) \n 0.1%\n\n  \n    \n   \n\nTorben Steen Jensen (Director)\nStrandvejen 60, 5\n2900 Hellerup\nDenmark \n 3,144,335(5) \n 16.3%\n\n  \n    \n   \n\nAll officers and directors as a group (7 persons) \n 3,710,308  \n 19.3%\n\n  \n    \n   \n\nKiri Lillan Glaesner\nDyrehavevej 3B\n2930 Klampenborg\nDenmark \n 3,259,025(6) \n 17.0%\n\n  \n    \n   \n\nAllan Traugott Wehnert\nDyrehavevej 3B\n2930 Klampenborg\nDenmark\n \n 5,296,131(7) \n 27.6%\n\n  \n    \n   \n\nChristian Hill-Madsen\n\nMesterlodden 3A, 1.\n\n2820 Gentofte\n\nDenmark\n\n \n 1,098,973(8) \n 5.7%\n\n \n\n \n(1)\nBased\non 19,798,896 shares of common stock as of June 18, 2026, composed of 19,173,896 outstanding shares of our common stock, 550,000\nshares of our common stock underlying outstanding incentive stock options and 75,000 shares of our common stock underlying outstanding\nwarrants.\n\n \n(2)\nIncludes\n15,333 shares of our common stock owned by Reddington Partners LLC, of which Mr. Rouf is the sole beneficial owner and 250,000 shares\nof our common stock underlying outstanding incentive stock options.\n\n \n(3)\nOn\nNovember 28, 2022, Mr. Yankowitz was granted a warrant to purchase 25,000 shares of our common stock at $10.00 per share. Also includes\n125,000 shares of our common stock underlying outstanding incentive stock options.\n\n \n(4)\nConsists of 72,399 shares owned by KTM ApS, a company 100% owned by Mr. Mücke, and 25,000 shares of our common\nstock underlying outstanding incentive stock options.\n\n \n(5)\nHeld\nthrough AC Nordic ApS, which is controlled by Mr. Jensen. Includes incentive stock options to purchase 25,000 shares.\n\n \n(6)\nHeld\nthrough GK Partners ApS, which is controlled by Mrs. Glaesner.\n\n \n(7)\nHeld\nthrough Alteral Therapeutics ApS, which Mr. Wehnert controls. Mr. Wehnert is the CEO of the Company’s subsidiaries Orocidin\nA/S, Bio-Convert A/S and NoviThera ApS.\n\n \n(8)\nHeld\nthrough ABCHill Holding ApS, which is controlled by Mr. Hill-Madsen. Mr. Hill-Madsen was formerly a director of the Company and is\nthe CEO of the Company’s subsidiary, NP Bioinnovation A/S.\n\n \n\n25"}